- Raised $20M Series A led by Shanghai Healthcare Capital, Nov 2022
- Raised $17M Seed round, Oct 2021
About
Biomica is a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI related disorders.
The company aims to identify and target microbes, metabolites and other microbiome-related components that are key in the etiology of human diseases impacted by the microbiome, using both biological and small-molecule approaches.
Biomica’s discovery and development efforts are powered by PRISM (Predictive, high Resolution, Integrative Selection of Microbes) platform. PRISM is a proprietary metagenomics analysis platform for functional genomics profiling utilizing internal comprehensive databases. Employing Biomica’s drug discovery approach, PRISM combines a profound understanding of the microbiome and its functions and their intricate relations with the human host.
Biomica is a subsidiary of Evogene.
Funding history · 2 rounds · $37.0M total
Headcount over time
Q&A
- What is Biomica's primary focus?
- Biomica is a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with a specific focus on Immuno-Oncology and GI related disorders.
- When was Biomica founded?
- Biomica was founded in June 2017.
- How much funding has Biomica raised to date?
- Biomica has raised a total of $37,000,000 USD across its funding rounds.
- When was Biomica's most recent funding round and who were the lead investors?
- Biomica's most recent funding round was an A Round in December 2022, which raised $20,000,000 USD. Shanghai Healthcare Capital was a lead investor.
- What is the name of Biomica's proprietary platform?
- Biomica's discovery and development efforts are powered by PRISM (Predictive, high Resolution, Integrative Selection of Microbes) platform, a proprietary metagenomics analysis platform.
- Who is the CEO of Biomica?
- Elran Haber is the CEO of Biomica.
- Is Biomica a subsidiary of another company?
- Yes, Biomica is a subsidiary of Evogene.
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | biomicamed.com |
|---|---|
| linkedin.com/company/28646072 | |
| Wikidata | wikidata.org/wiki/Q107519036 |
Identifiers & details
| Founded | 2017-6 |
|---|---|
| Employees (exact) | 14 |
| Wikidata QID | Q107519036 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Publications (Crossref)
| Works | 7 |
|---|
Web history (Wayback)
| Domain | biomicamed.com |
|---|
Wikidata
| QID | Q107519036 |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515623411 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-03-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 9 — violation (1), annual_report (4), people (3), other (1) |
| Registered address | פינשטיין 13 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2026-04-23 | דו~ח שנתי-עדכון כתובת |
| 2026-04-23 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-04-20 | עדכון בעלי תפקידים |
| 2026-04-20 | משפטי כללי / תגובה לבית משפט- הערה לנסח |
| 2025-10-19 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2025-10-19 | דו~ח שנתי-הוספת בעל תפקיד |
| 2026-03-09 | עדכון דירקטורים-הוספת דירקטור |
| 2026-03-09 | עדכון דירקטורים-הסרת דירקטור |